Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CRMD - NASDAQ: CRMD Investor Notice: Update in Lawsuit against CorMedix Inc. announced by the Shareholders Foundation


CRMD - NASDAQ: CRMD Investor Notice: Update in Lawsuit against CorMedix Inc. announced by the Shareholders Foundation

SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of the CorMedix Inc. (NASDAQ: CRMD).

Investors, who purchased shares of CorMedix Inc. (NASDAQ: CRMD) prior to July 2020 and continue to hold any of those NASDAQ: CRMD shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On July 22, 2021, a lawsuit was filed against CorMedix Inc. over alleged securities laws violations. The plaintiff alleged that the defendants made material misrepresentations concerning the following: (i) deficiencies existed with respect to DefenCath's manufacturing process and/or at the facility responsible for manufacturing DefenCath; (ii) in light of the foregoing deficiencies, the FDA was unlikely to approve the DefenCath NDA for CRBSIs in its present form; (iii) Defendants had downplayed the true scope of the deficiencies with DefenCath's manufacturing process and/or at the facility responsible for manufacturing DefenCath; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

On December 14, 2021, a consolidated Complaint was filed and February 21, 2022, certain defendants filed their motion to dismiss the consolidated complaint.

Those who purchased CorMedix Inc. (NASDAQ: CRMD) prior to July 2020 and continue to hold any of those NASDAQ: CRMD shares, should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.


Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com

Menu

CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...